Henrik S Rasmussen

Title: Innovations in Cancer Treatment by Henrik S. Rasmussen

Introduction

Henrik S. Rasmussen is a notable inventor based in Arnold, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing adenoviral vectors to enhance therapeutic regimens for cancer patients.

Latest Patents

Henrik S. Rasmussen holds a patent for a therapeutic regimen aimed at treating cancer. The patent, titled "Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene," outlines a method for treating tumors in humans. This method involves administering a pharmaceutical composition that includes a replication-deficient adenoviral vector with a nucleic acid sequence encoding TNF-α. The treatment regimen is designed to be administered over a therapeutic period of up to 10 weeks, with a specific dosage of adenoviral vector particles.

Career Highlights

Henrik S. Rasmussen is associated with GenVec, Inc., where he continues to advance his research in cancer therapies. His work has the potential to significantly impact the way tumors are treated, offering new hope to patients battling cancer.

Collaborations

Henrik has collaborated with esteemed colleagues such as Karen W. Chu and Paul D. Kessler. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer treatments.

Conclusion

Henrik S. Rasmussen's contributions to cancer treatment through his patent and work at GenVec, Inc. highlight the importance of innovation in medical research. His efforts are paving the way for more effective therapies that could change the landscape of cancer treatment.